Toxicologic Pathology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Philbert, M. A.
Right arrow Articles by Reuhl, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Philbert, M. A.
Right arrow Articles by Reuhl, K. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Toxicologic Pathology, Vol. 28, No. 1, 43-53 (2000)
DOI: 10.1177/019262330002800107

Mechanisms of Injury in the Central Nervous System

Martin A. Philbert

Neurotoxicology and Experimental Neuropathology Labs, Environmental Health Sciences, University of Michigan, Ann Arbor, Michigan 48109-2029

Melvin L. Billingsley

Department of Pharmacology, College of Medicine, Pennsylvania State University, Hershey, Pennsylvania 17033

Kenneth R. Reuhl

Neurotoxicology Laboratories, College of Pharmacy, Rutgers-The State University of New Jersey, Piscataway, New Jersey 08854

Neurotoxicants with similar structural features or common mechanisms of chemical action frequently produce widely divergent neuropathologic outcomes. Methylmercury (MeHg) produces marked cerebellar dysmorphogenesis during critical periods of development. The pathologic picture is characterized by complete architectural disruption of neuronal elements within the cerebellum. MeHg binds strongly to protein and soluble sulphydryl groups. Binding to microtubular -SH groups results in catastrophic depolymerization of immature tyrosinated microtubules. However, more mature acetylated microtubules are resistant to MeHg-induced depolymerization. In contrast to MeHg, the structurally similar organotin trimethyltin (TMT) elicits specific apoptotic destruction of pyramidal neurons in the CA3 region of the hippocampus and in other limbic structures. Expression of the phylogenetically conserved protein stannin is required for development of TMT-induced lesions. Inhibition of expression using antisense oligonucleotides against stannin protects neurons from the effects of TMT, suggesting that this protein is required for expression of neurotoxicity. However, expression of stannin alone is insufficient for induction of apoptotic pathways in neuronal populations. The aromatic nitrocompound 1,3-dinitrobenzene (DNB) has 2 independent nitro groups that can redox cycle in the presence of molecular oxygen. Despite its ability to deplete neural glutathione stores, DNB produces edematous gliovascular lesions in the brain stem of rats. Glial cells are susceptible despite high concentrations of reduced glutathione compared with neuronal somata in the central nervous system (CNS). The severity of lesions produced by DNB is modulated by the activity of neurons in the affected pathways. The inherent discrepancy between susceptibility of neuronal and glial cell populations is likely mediated by differential control of the mitochondrial permeability transition in astrocytes and neurons. Lessons learned in the mechanistic investigation of neurotoxicants suggest caution in the evaluation and interpretation of structure-activity relationships, eg, TMT, MeHg, and DNB all induce oxidative stress, whereas TMT and triethyltin produce neuronal damage and myelin edema, respectively. The precise CNS molecular targets of cell-specific lipophilic neurotoxicants remain to be determined.

Key Words: Central nervous system • 1,3-dinitrobenzene • mechanisms • methylmercury • neurotoxicity • organometals • stannin • trimethyltin


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
F. Grun, H. Watanabe, Z. Zamanian, L. Maeda, K. Arima, R. Cubacha, D. M. Gardiner, J. Kanno, T. Iguchi, and B. Blumberg
Endocrine-Disrupting Organotin Compounds Are Potent Inducers of Adipogenesis in Vertebrates
Mol. Endocrinol., September 1, 2006; 20(9): 2141 - 2155.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Grun and B. Blumberg
Environmental Obesogens: Organotins and Endocrine Disruption via Nuclear Receptor Signaling
Endocrinology, June 1, 2006; 147(6): s50 - s55.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. E. Reese, C. Davidson, M. L. Billingsley, and J. Yun
Protein Kinase C{epsilon} Regulates Tumor Necrosis Factor-{alpha}-Induced Stannin Gene Expression
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 61 - 69.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. E. Davidson, B. E. Reese, M. L. Billingsley, and J. K. Yun
Stannin, A Protein That Localizes to the Mitochondria and Sensitizes NIH-3T3 Cells to Trimethyltin and Dimethyltin Toxicity
Mol. Pharmacol., October 1, 2004; 66(4): 855 - 863.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
P. Gunasekar, L. Li, K. Prabhakaran, V. Eybl, J. L. Borowitz, and G. E. Isom
Mechanisms of the Apoptotic and Necrotic Actions of Trimethyltin in Cerebellar Granule Cells
Toxicol. Sci., November 1, 2001; 64(1): 83 - 89.
[Abstract] [Full Text] [PDF]